compound introduction
trans-Pralsetinib (trans-BLU-667) is a rearranged during transfection (RET) inhibitor extracted from patent US20170121312A1, Compound Example 129 Form:Solid IC50& Target:RET
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
trans-Pralsetinib
CAS number：2097132-93-7 molecular formula：C27H32FN9O2
overview
Specs
| Chinese alias | 反式普拉司替尼 | ||
| English alias | :PRALSETINIB [ORANGE BOOK] | BLU123244 | BLU-123244 | X581238 | X-581238 | WHO 11004 | BDBM435010 | Pralsetinib [USAN] | SCHEMBL18789228 | cyclohexanecarboxamide, N-[(1S)-1-[6-(4-fluoro-1H-pyrazol-1-yl)-3-pyridinyl]ethyl]-1-methoxy-4-[4-methyl-6-[(5-methy | ||
| CAS number | 2097132-93-7 | molecular formula | C27H32FN9O2 |
| molecular weight | 533.60 g/mol | Exact mass | ≥96% |
| PSA | 136.000 Ų | logp | 3.1 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS
